Rapidly growing lipoma as the syndrome of lipodystrophy in HIV-infected child

Katarzyna Mazur-Melewska 1 , Tomasz Macedulski 1 , Sebastian Moryciński 2 , Anna Mania 1 , Ewa Trejster 3 , Magdalena Figlerowicz, Justyna Pohland, Przemysław Mańkowski 2 , and Wojciech Służewski 1
  • 1 Department of Infectious Diseases and Child Neurology, Karol Marcinkowski University of Medical Sciences in Poznań, 60-355, Poznań, Poland
  • 2 Department of Surgery, Traumatology and Chidren’s Urology Karol Marcinkowski, Univesity of Medical Sciences in Poznań, 60-355, Poznań, Poland
  • 3 Department of Patomorfology Karol Jonscher Hospital in Poznań, 60-572, Poznań, Poland
  • 4 The President Stanislaw Wojciechowski Higher Vocational, State School in Kalisz, 62-800, Kalisz, Poland


If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] Rydholm A, Berg NO. Size, site and clinical incidence of lipoma: factors in the differential diagnosis of lipoma and sarcoma. Acta Orthop Scand 1983; 54: 929–934 http://dx.doi.org/10.3109/17453678308992936

  • [2] Davis C and Gruhn JG: Giant lipoma of the thigh. Arch Surg 1967; 95: 151–156 http://dx.doi.org/10.1001/archsurg.1967.01330130153030

  • [3] Harrington AC, Adnot J, Chesser R: Infiltrating lipomas of the upper extremities. J Dermatol Surg Oncol 1990; 16: 834–837

  • [4] Sanchez MR, Golomb FM, Moy JA, Potozkin JR: Giant lipoma: case report and review of the literature. J Am Acad Dermatol 1993; 28: 266–268 http://dx.doi.org/10.1016/S0190-9622(08)81151-6

  • [5] Mazzochi M., Onesti MG, Pasquinni P. et al. Giant Fibrolipoma in the Leg — A Case Report Anticancer Research 2006; 26: 3649–3654

  • [6] Leonard E, McComsey G. Metabolic complications of antiretroviral therapy in children. Pediatr Infect Dis J 2003; 22: 77–84 http://dx.doi.org/10.1097/00006454-200301000-00018

  • [7] Sánchez-Torres AM, Muñoz-Muñíz R, Madero R et al. Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children. Eur J Pediatr 2005;164:271–276. http://dx.doi.org/10.1007/s00431-004-1610-y

  • [8] Innes S, Levin L, Cotton M. Lipodystrophy syndrome in HIV-infected children on HAART South Afr J HIV Med. 2009; 10: 76–80

  • [9] POPIELSKA J Lipodystrofia u dzieci zakażonych HIV. Pol Merk Lek, 2008; 143, 408–413

  • [10] Hazra R, Siberry G, Mofenson L. Growing Up with HIV: Children, Adolescents and Young Adults with Perinatally Acquired HIV Infection. An Rev Med 2010; 61: 169–185 http://dx.doi.org/10.1146/annurev.med.050108.151127

  • [11] Worell CJ Metabolic complication of antiviral therapy. in: Handbook of Pediatric HIV Care Edited by: Zeichner SL, Read JS. Cambridge 2006

  • [12] Muñoz-Hernández MR, Fat NP. Predistribution and metabolic disturbances in HIV-infected children and adolescents under highly active antiretroviral therapy (HAART). Bol Med Hosp Infant Mex 2009; 66: 41–46

  • [13] European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS 2004, 18:1443–1451 http://dx.doi.org/10.1097/01.aids.0000131334.38172.01


Journal + Issues